Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Work In Process: 2021-2024

Historic Work In Process for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to $10.4 million.

  • Burning Rock Biotech's Work In Process fell 27.52% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 27.52%. This contributed to the annual value of $10.4 million for FY2024, which is 9.68% down from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Work In Process is $10.4 million, which was down 9.68% from $11.5 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Work In Process peaked at $11.5 million during FY2023, and registered a low of $8.9 million during FY2021.
  • Over the past 3 years, Burning Rock Biotech's median Work In Process value was $11.2 million (recorded in 2022), while the average stood at $11.0 million.
  • Its Work In Process has fluctuated over the past 5 years, first rose by 25.95% in 2022, then fell by 9.68% in 2024.
  • Burning Rock Biotech's Work In Process (MRY) stood at $8.9 million in 2021, then rose by 25.95% to $11.2 million in 2022, then grew by 2.17% to $11.5 million in 2023, then decreased by 9.68% to $10.4 million in 2024.
  • Its Work In Process was $10.4 million in FY2024, compared to $11.5 million in FY2023 and $11.2 million in FY2022.